Atenolol 25mg bottles mislabeled; contain Clopidogrel 75mg tablets
Golden State Medical Supply Inc. is recalling 2,584 bottles of Atenolol 25mg tablets nationwide. Bottles labeled as Atenolol 25mg actually contain Clopidogrel 75mg tablets—a different medication.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall. Although no illnesses or injuries have been reported, receiving an entirely different medication poses a serious risk to patient safety. FDA Class I classification requires a minimum severity score of 4.
Plain-English summary
Golden State Medical Supply Inc. is recalling 2,584 bottles of Atenolol 25mg tablets (Lot #GS046745, expiration 12/2023) due to a labeling error. Bottles labeled and intended to contain Atenolol 25mg actually contain Clopidogrel 75mg tablets.
Atenolol is a beta-blocker used to treat hypertension and angina. Clopidogrel is an antiplatelet agent used to reduce clot risk. These medications have different therapeutic purposes and different safety profiles. Patients who receive the wrong medication would not receive their intended treatment and could face serious health risks.
The affected product was distributed nationwide. Consumers who have received bottles from lot GS046745 should not take the product and should contact their healthcare provider or pharmacist immediately for guidance. Return the affected bottles to the dispensing pharmacy.
The recalled product
- Product
- ATENOLOL (ATENOLOL)
- Brand
- ATENOLOL
- Manufacturer
- Golden State Medical Supply Inc.
- Category
- Drug — Prescription Medication
- Hazard
- medication-mix-up
- labeling-error
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: GS046745
- Exp 12/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27